Education
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
Vir Biotechnology (VIR) Ownership Overview
15.16% Insiders
13.56% Mutual Funds
22.39% Other Institutional Investors
21.33% ETFs
27.55% Public Companies and
Individual Investors
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. Approximately 57.28% of the company’s stock is owned by Institutional Investors, 15.16% is owned by Insiders, and 27.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 25, 2025 | Vanina De Verneuil Evp & Gc | xxxxxxxxxxxxx | $48573 |
| Feb 25, 2025 | Ann M. Hanly Evp & Cto | xxxxxxxxxxxxx | $133888 |
| Feb 25, 2025 | George Scangos Director | xxxxxxxxxxxxx | $95029 |
| Feb 25, 2025 | Marianne De Backer Ceo,director | xxxxxxxxxxxxx | $152353 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $596375 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $991164 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $7960516 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,534,704 | Insider | 9.87% | 96,773,134 | |
| 11,483,524 | Institution | 8.37% | 82,107,197 | |
| 10,512,293 | Institution | 7.67% | 75,162,895 | |
| 9,190,686 | Institution | 6.70% | 65,713,405 | |
| 3,813,528 | Insider | 2.78% | 27,266,725 | |
| 2,945,276 | Institution | 2.15% | 21,058,723 | |
| 1,312,391 | Insider | 0.96% | 9,383,596 | |
| 1,182,435 | Institution | 0.86% | 8,454,410 | |
| 1,084,539 | Institution | 0.79% | 7,754,454 | |
| 1,016,319 | Institution | 0.74% | 7,266,681 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,190,686 | Institution | 6.70% | 65,713,405 | |
| 1,016,319 | Institution | 0.74% | 7,266,681 | |
| 914,071 | Institution | 0.67% | 6,535,608 | |
| 901,518 | Institution | 0.66% | 6,445,854 | |
| 600,374 | Institution | 0.44% | 4,292,674 | |
| 564,946 | Institution | 0.41% | 4,039,364 | |
| 518,218 | Institution | 0.38% | 3,705,259 | |
| 490,242 | Institution | 0.36% | 3,505,230 | |
| 487,024 | Institution | 0.36% | 3,482,222 | |
| 460,198 | Institution | 0.34% | 3,290,416 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,824,172 | Institution | 4.25% | 41,642,830 | |
| 3,440,500 | Institution | 2.51% | 28,865,795 | |
| 2,805,740 | Institution | 2.05% | 20,594,132 | |
| 2,435,586 | Institution | 1.78% | 17,414,440 | |
| 1,585,852 | Institution | 1.16% | 16,492,861 | |
| 1,385,803 | Institution | 1.01% | 11,626,887 | |
| 1,261,100 | Institution | 0.92% | 8,827,700 | |
| 975,676 | Institution | 0.71% | 6,976,083 | |
| 822,555 | Institution | 0.60% | 5,881,268 | |
| 821,144 | Institution | 0.60% | 5,748,008 |
FAQ
Who Owns Vir Biotechnology (VIR)?
According to the latest TipRanks data, approximately 22.39% of the company's stock is held by institutional investors, 15.16% is held by insiders, and 27.55% is held by retail investors.
What percentage of Vir Biotechnology (VIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.39% of Vir Biotechnology (VIR) stock is held by institutional investors.
What percentage of Vir Biotechnology (VIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.55% of Vir Biotechnology (VIR) stock is held by retail investors.
Who owns the most shares of Vir Biotechnology (VIR)?
Robert Nelsen owns the most shares of Vir Biotechnology (VIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.